2016newlogowords
December AACT Section Webinar “Gaboon Viper Envenomation
Mr pencil

How would you like your name to appear on your certificate?



How many credit hours did you complete?
Agreement
By completing this form, you attest that you have attended the number of hours you have indicated above.
Was the educational content of value to you?
Was the educational content scientifically sound?
If no, please explain...
Did you perceive any commercial bias or influence in the educational content?
If yes, please explain...
Did this activity improve your Skills or Strategy?
If yes, how...
Do you think what you learned will benefit you in your practice?
If yes, how...
Tell us what was good or bad about any part of the educational activity, content, speakers, materials, anything
What questions are you having in your practice that you would like to see addressed in an educational activity?
PHARMACISTS: If you do not provide your NABP ID AND your DATE OF BIRTH, your hours will not be uploaded to CPE Monitor.
(CPE Monitor) NABP e-Profile ID (ePID) - Example 123456:
(CPE Monitor) Date of Birth (MM/DD) - Example September 24 would be 0924: 
Please rate Natasha Tobarran, DO
Content/Teaching Methods
Presentation/Handouts
Relevance of Content to Objectives
Independence, Objectivity, Balance, Scientific Rigor
Please rate Emily Kershner, MD
Independence, Objectivity, Balance, Scientific Rigor
Relevance of Content to Objectives
Presentation/Handouts
Content/Teaching Methods
Please rate Nick Brandehoff, MD
Independence, Objectivity, Balance, Scientific Rigor
Relevance of Content to Objectives
Presentation/Handouts
Content/Teaching Methods
Were the learning objectives met?
Describe the excepted clinical course after a Gaboon viper envenomation.

Discuss the role of expired antivenom and North American Crotalid Antivenom in Gaboon viper envenomations. 

Riview the risk of delayed coagulopathy and serum sickness after antivenom treatment.
When you viewed this webinar, were you in a group or by yourself?
If in a group, with how many people?
Comments:
Mr question